Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
China's WuXi Biologics launches WuXia RidGS for non-antibiotic cell line development

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

October 29, 2024 | Tuesday | News
Samsung Biologics inks largest ever manufacturing deal of $1.24 B with Asia-based pharma

South Korea-based Samsung Biologics, a global contract development and manufacturing organization (CDMO), has annou...

October 22, 2024 | Tuesday | News
EirGenix's comprehensive CDMO services strengthening Taiwan's position in the global biopharmaceutical landscape

EirGenix (HQ: Taipei, Taiwan), an established Taiwanese Contract Development and Manufacturing Organization (CDMO), spec...

October 4, 2024 | Friday | Opinion
Bora Appoints J.D. Mowery as First Division President of its CDMO biz

Taiwan-based Bora Pharmaceuticals Co. has announced the appointment of J.D. Mowery to the newly created position of Divi...

October 3, 2024 | Thursday | News
SK pharmteco invests $260 M in Korea facility to expand global small molecule and peptide production

US-headquartered SK pharmteco, a global contract development and manufacturing organisation (CDMO), has announced a majo...

October 1, 2024 | Tuesday | News
Cytiva opens its first Innovation Hub in South Korea

Cytiva, a global life sciences leader, has opened its first Innovation Hub in Korea, located in the Songdo Bio-cluster i...

September 30, 2024 | Monday | News
Thermo Fisher Scientific expands oral solid dose development and manufacturing capabilities across North America

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutic...

September 26, 2024 | Thursday | News
Korea's Samsung Biologics launches development platforms for enhanced therapeutic efficacy

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has launched a...

September 26, 2024 | Thursday | News
Taiwan's Bora Pharmaceuticals makes strategic investment into Tanvex for global biomanufacturing services

Taiwan-based Bora Pharmaceuticals Co. has announced that its Board of Directors has approved a strategic investment into...

August 28, 2024 | Wednesday | News
Korean CDMO ST Pharm accelerates manufacturing of RNA-based vaccines therapeutics with Quantoom Biosciences

ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...

August 20, 2024 | Tuesday | News
Andelyn Biosciences Expands AAV Curatorâ„¢ Platform with Broad Institute's MyoAAV Plasmids

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

August 7, 2024 | Wednesday | News
Lotte Biologics invests approx 4.6 trillion won for new plant in South Korea

In a landmark event signaling its ambitious foray into the biopharmaceutical sector, Lotte Biologics, under the leadersh...

July 5, 2024 | Friday | News
Porton Advanced introduces MaxCyte ExPERT GTx Flow Electroporation instrument for cell therapy

Porton Advanced, a subsidiary of China headquartered contract development and manufacturing organisation (CDMO) Porton P...

June 26, 2024 | Wednesday | News
Taiwan's Bora Pharma buys US-based Emergent BioSolutions' manufacturing site for $30 M

US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimo...

June 24, 2024 | Monday | News
Vetter announces plans to expand capacity in US and Germany

Vetter, a leading global contract development and manufacturing organization (CDMO), has announced its plans to move and...

June 7, 2024 | Friday | News
Japan's Asahi Kasei to establish facility in US and launch plasmid DNA business

Asahi Kasei Medical's US subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new busin...

June 4, 2024 | Tuesday | News
Thermo Fisher opens ultra-cold facility in EU to accelerate advanced therapies development

US-based Thermo Fisher Scientific Inc. has opened a new clinical and commercial ultra-cold facility in the European Unio...

June 3, 2024 | Monday | News
CPHI North America expanding Bioproduction focus for 2025

CPHI North America reports soaring attendance and palpable excitement on the show floor, as investment returns and biolo...

May 9, 2024 | Thursday | News
Merck KGaA Darmstadt Germany announces largest investment in Asia

Merck KGaA Darmstadt Germany has announced its largest investment in Asia through a groundbreaking ceremony of its state...

May 29, 2024 | Wednesday | News
“There's a growing focus on developing novel ADCs tailored to address unmet medical needs”

Can you provide an overview of Nona Biosciences' integrated antibody discovery services? Nona Biosciences is a global l...

May 31, 2024 | Friday | Opinion
Asahi Kasei completes construction of third assembly plant for Planova virus removal filters in Japan

Asahi Kasei Medical has completed the construction of its third assembly plant for Planova virus removal filters in Nobe...

May 27, 2024 | Monday | News
WuXi AppTec breaks ground on new R&D and manufacturing site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...

May 23, 2024 | Thursday | News
West Pharma Services opens new office and warehouse facility in South Korea

West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administrati...

May 23, 2024 | Thursday | News
Sartorius partners with Sanofi to commercialise downstream process intensification platform

Germany-based life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop a...

May 13, 2024 | Monday | News